A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx Paclitaxel-Coated Conformer Coronary Stent
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Coronary disorders; Myocardial ischaemia; Restenosis; Unstable angina pectoris
- Focus Registrational; Therapeutic Use
- Acronyms TAXUS-II
- Sponsors Boston Scientific Corporation
- 13 Oct 2009 Final 5-year results published in Circulation.
- 29 Nov 2007 New trial record.